Latest news

Clinical

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Antisense therapeutic AstraZeneca and Ionis Pharmaceuticals drug Wainua did not demonstrate a significant cardiovascular advantage in a Phase 3...
Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market, the drug class has yet to fully meet the high...
Commercial

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

Vogenx is preparing to enter the public markets by filing for a Nasdaq listing, with plans to use the...
Clinical

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Axiom Biosciences has reported results from a phase 1 clinical trial evaluating an umbilical cord-derived mesenchymal stem cell (MSC)...
Commercial

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Spero Therapeutics is reshaping its strategy by shifting its...
Research & Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Biogen has presented phase 2 results for diranersen, an...
Commercial

Insilico Joins Hands With CDMO Bora in AI Drug Discovery Deal Worth $2.5B

Generative AI leader Insilico Medicine has added another major pharmaceutical collaboration to its growing list of partnerships, this time...
Clinical

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

Kelun-Biotech and Merck & Co.’s antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) has achieved a positive result in the Phase 3...
Insights

The Future of Smart Biopharmaceutical Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering a period of profound transformation. For decades, manufacturing excellence was largely defined by scale, process...
Insights

Top 10 Risks Pharma Leaders Underestimate in AI Deployment

Pharma Leaders:Executive Summary Artificial intelligence is rapidly becoming a strategic...
Clinical

Veradermics Reports Phase 2 Results for VDPHL01 in Women With Pattern Hair Loss

Veradermics has reported topline results from an open-label Phase...
Clinical

Dysport Meets Phase 3 Goals in Episodic and Chronic Migraine Trials

Ipsen announced that its neurotoxin Dysport achieved the primary goals in two Phase 3 clinical trials evaluating the treatment...
Clinical

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

Johnson & Johnson has reported results from the pivotal phase 2/3 Energy study evaluating Imaavy in patients with warm...
Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D of the Phase 2 CIRRUS-HCM trial evaluating EDG-7500 in patients...
Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market,...
Editorial Team -
Commercial

Sanofi snags rare drug INBRX-101 in a bid to pioneer biotech advancements

Sanofi, the prominent pharmaceutical conglomerate, has undertaken a recent...
Commercial

AstraZeneca’s $2 Billion Acquisition of Fusion Pharmaceuticals Signals Surge in Radiopharmaceutical Interest

AstraZeneca's decision to integrate Fusion Pharmaceuticals into its cancer...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market,...
Editorial Team -
Regulatory

Merck Makes History By Getting FDA Green Light For Lipfendra

A decade after PCSK9 inhibitors first entered the market,...
Commercial

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

Vogenx is preparing to enter the public markets by...
Clinical

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Axiom Biosciences has reported results from a phase 1...
Commercial

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

AstraZeneca has committed to spending up to $1.5 billion...

Research & Development

Market Access

Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...
Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Antisense therapeutic AstraZeneca and Ionis Pharmaceuticals drug Wainua did...
Editorial Team -